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Overlapping characteristics of Brugada syndrome (BrS) and arrhythmogenic right ventricular cardio-
myopathy/dysplasia (ARVC/D) have been reported in recent studies, but little is known about the over-
lapping disease state of BrS and ARVC/D. A 36-year-old man, hospitalized at our institution for syncope,
presented with this overlapping disease state. The electrocardiogram showed spontaneous coved-type
ST-segment elevation, and ventricular ﬁbrillation was induced by right ventricular outﬂow tract stimu-
lation in an electrophysiological study. BrS was subsequently diagnosed; additionally, the presence of
epsilon-like waves and right ventricular structural abnormalities met with the 2010 revised task force
criteria for ARVC/D. After careful investigation for both BrS and ARVC/D, an implantable cardioverter
deﬁbrillator was inserted in the patient. This case revealed 2 important clinical ﬁndings: (1) BrS and
ARVC/D clinical features can coexist in a single patient, and EPS might be useful for determining the
phenotype of overlapping disease (e.g., BrS-like or ARVC/D-like). (2) An overlapping disease state of BrS
and ARVC/D can change phenotypically during its clinical course. Therefore, careful examination and
attentive follow-up are required for patients with BrS or ARVC/D.
& 2015 Japanese Heart Rhythm Society. Published by Elsevier B.V. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Brugada syndrome (BrS) is characterized by right precordial ST-
segment elevation followed by a negative T wave and sudden
cardiac death from ventricular ﬁbrillation in patients with struc-
turally normal hearts [1]. Recent studies have revealed structural
or electrocardiographic abnormalities, such as right ventricular
dilatation or epsilon-like waves, in some patients with BrS [2,3].
These abnormalities are commonly considered characteristics of
arrhythmogenic right ventricular cardiomyopathy/dysplasia
(ARVC/D). It is generally known that there are clinical similarities
between BrS and ARVC/D [4]; however, little is known about the
clinical features of patients with an overlapping disease state of
BrS and ARVC/D, and accordingly, treatment of such patients
remains poorly understood. In order to understand this condition
better, we report here, a case of overlapping disease state of BrS
and ARVC/D.blished by Elsevier B.V. This is an
þ81 3 3353 6793.
. Kataoka).2. Case report
A 36-year-old man presented to our institution with syncope,
and was subsequently, hospitalized. He had no family history of
sudden cardiac death. The electrocardiogram (ECG) showed
spontaneous coved-type ST-segment elevation (Brugada type
1 ECG); we initially suspected BrS. In an electrophysiological study
(EPS) conducted prior to pilsicainide infusion, neither ventricular
tachycardia (VT) nor ventricular ﬁbrillation (VF) was induced by a
single or double stimulus to the right ventricular apex or right
ventricular outﬂow tract. A single stimulus to the right ventricular
outﬂow tract during pilsicainide infusion induced ventricular
ﬁbrillation, which was thereafter, inhibited during isoproterenol
infusion. Therefore, the patient was diagnosed with BrS, although
the clinical presentation differed from typical BrS to some extent.
First, the chest radiograph and cardiovascular magnetic resonance
imaging (CMR) showed mild right ventricular (RV) dilatation
(Fig.1A, B). Second, RV angiography demonstrated RV dilatation
and akinesis in the inferior wall (Fig.1C, D), although coronary
angiography did not show critical stenosis, and the provocation
test failed to induce coronary spasm. Finally, epsilon-like waves
were seen in spontaneous type 1 ECG (Fig.2). As a result, the
patient not only met the diagnostic criteria for BrS but also met theopen access article under the CC BY-NC-ND license
Fig. 1. (A)Chest radiograph reveals mild right ventricle dilatation. (B) Cardiovascular magnetic resonance imaging shows mild right ventricle dilatation and no late gado-
linium enhancement. (C) Right ventricular angiography demonstrates right ventricular dilatation and akinesis in the inferior wall. (D) Computed tomography does not reveal
fatty change in the right ventricular myocardium.
Fig. 2. The patient’s electrocardiogram shows spontaneous coved-type ST-segment elevation and epsilon-like waves in type 1 ECG.
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Table 1
Clinical characteristics of the present case.
Age at presentation 36 years old
Sex Male
QTc 416 ms
Head-up tilt test Negative
Atrial arrhythmias None
AV conduction Normal
CAG No signiﬁcant stenosis
LVEF 47%
RVEF 43%
LVEDV(I) / ESV(I) 136(76) / 68(39) ml (ml/m2)
RVEDV(I) / ESV(I) 233(134) / 134(77) ml (ml/
m2)
Spasm provocation test Negative
CMR No Late gadolinium
enhancement
Characteristics of ARVC
/ D
Symptoms Syncope
Family history of
ARVC/D
None
RV angiography Regional RV akinesis
ECG depolarization Epsilon wave
Late potentials f-QRS¼174 ms,
LAS40¼79 ms,
RMS40¼7.7 μV
ECG changes Fixed
Imaging RV dilatation
Gene mutation of
ARVC/D
None
Characteristics of BrS Symptoms Syncope
Family history of SCD None
Family history of BrS None
ECG repolarization Spontaneous coved-type ST
segment elevation
Ventricular
arrhythmias
VF/Polymorphic VT (induced
in the EPS)
Beta-stimulation Inhibited (in the EPS)
Pathology Not speciﬁc
Gene mutation of BrS None
ARVC/D¼Arrhythmogenic right ventricular cardiomyopathy/dysplasia , AV con-
duction¼atrioventricular conduction, BrS¼Brugada syndrome, CAG¼coronary
angiography, CMR¼cardiovascular magnetic resonance, EPS¼electrophysiological
study, f-QRS¼ﬁltered QRS, LAS40¼duration of terminal QRSo40 μV, LVEF¼ left
ventricular ejection fraction, LVEDV (I)¼ left ventricular end-diastolic volume
(index), LVESV(I)¼ left ventricular end-systolic volume(index), QTc¼corrected QT
interval, RMS40¼root-mean-square voltage of terminal 40 ms, RV¼right ventricle,
RVEF¼right ventricular ejection fraction, RVEDV(I)¼right ventricular end-diastolic
volume(index), RVESV(I)¼right ventricular end-systolic volume(index),
SCD¼sudden cardiac death, VF¼ventricular ﬁbrillation, VT¼ventricular
tachycardia
Table 2
Analyzed gene mutations.
Gene Phenotype
RYR2 CPVT1/ARVC2
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(regional RV akinesis by RV angiography and the presence of an
epsilon wave in the right precordial leads). The patient was dis-
charged from the hospital after insertion of an implantable car-
dioverter deﬁbrillator (ICD).SCN5A LQTS/BrS1
CACNA1C LQT8/BrS3
CACNB2 BrS4
CACNA2D1 BrS9
SCN1B BrS5
SCN3B BrS7
GPD1L BrS2
KCND3 BrS10
KCNJ8 ERS1/BrS8
KCNE3 BrS6
KCNE4
KCNE5 BrS/IVF
SCN10A BrS
MOG1 (RANGRF) BrS11
DSP ARVC8
PKP2 ARVC9
DSG2 ARVC10
DSC2 ARVC11
JUP ARVC123. Discussion
In this case study, we determined 2 important clinical issues. First,
the phenotype of an overlapping disease state for BrS and ARVC/D
may vary between individuals, and therefore, EPS may be useful for
determining the phenotype of an overlapping disease (e.g., BrS-like or
ARVC/D-like). Second, careful examination is needed to conﬁrm
diagnosis in the cases suspected of overlapping BrS and ARVC/D, and
to determine better treatment course for these patients.
Although presentation of the overlapping disease state may
vary among patients, past investigations have demonstrated some
common features of the overlap. First, sodium channel blockers
can induce BrS ECG in a subgroup of patients with ARVC/D [5], and
epsilon-like waves are seen in some patients with type 1 ECG.Epsilon-like waves are more common in drug-induced type 1 ECGs
than in spontaneous type 1 ECGs [3]. Rather than using the term
“epsilon wave,” we use the term “epsilon-like wave” because
distinguishing the epsilon wave from the fragmented QRS wave
was difﬁcult. The epsilon wave is located between the end of the
QRS complex and beginning of the T-wave. In contrast, a frag-
mented QRS (f-QRS) is deﬁned as the presence of additional spikes
within the QRS complex. In patients with BrS, deﬁning the end of
QRS complex is difﬁcult, and it is still controversial where the J
wave represents depolarization component or repolarization
component. Therefore, occurrence of additional spikes at the end
of QRS complex or immediately after the QRS complex in BrS is not
certain. The term “epsilon-like wave” has been used to avoid such
discrepancies in ECG interpretation. [3] Some previous studies
revealed that epsilon potentials and QRS fragmentation have
similarly high diagnostic values, and epsilon-like potentials in
different leads at the beginning, top, or end of the QRS complex
are typical ECG ﬁndings in patients with ARVC/D. [6,7]. Second,
imaging studies have revealed RV wall motion abnormalities or RV
dilatation, which are characteristic of ARVC/D, in some patients
with BrS [2,8]. Third, the ﬁbro-fatty replacements required to
diagnose ARVC/D have been detected during endocardial biopsies
of patients with type 1 ECG [9]. Finally, speciﬁc gene mutations
involving ARVC/D have been identiﬁed in some patients with BrS
[10]. These overlapping features are considered a result either of
genetic interactions or of the combined inﬂuence of BrS’ electro-
physiological abnormalities and ARVC/D's structural abnormal-
ities. Accordingly, ARVC/D patients can satisfy the diagnostic cri-
teria of BrS, and BrS patients can satisfy the diagnostic criteria of
ARVC/D.
A disease state combining both conditions has a different
clinical course than uncomplicated BrS. A subgroup of BrS patients
may demonstrate the features of ARVC/D long after the initial BrS
diagnosis. Structural heart diseases and histological ﬁndings con-
sistent with ARVC/D have been revealed after autopsy of patients
who were diagnosed with BrS and who died suddenly [11]. Thus,
careful observation of the changing clinical course is vital and may
indicate the transformation from BrS to ARVC/D.
Detailed evaluation in the cases of suspected overlap of BrS and
ARVC/D is also needed to determine a better treatment course for
these patients. In this case, we used a range of methods, from
physical examination to genetic testing (BrS- and ARVC/D-spe-
ciﬁc), to conﬁrm dual diagnosis and to determine a better course
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sode of syncope, demonstrated epsilon-like waves in spontaneous
type 1 ECG, and showed RV dilatation and RV wall motion
abnormalities, a diagnosis of overlap disease of BrS and ARVC/D for
the patient can be asserted with certainty.
Although treating patients with BrS features in the case of
structural heart disease remains challenging, this patient received
an ICD because of spontaneous type 1 ECG and an episode of
syncope. Nevertheless, the phenotype of this case may change in
future, demonstrating clinical features of ARVC/D, such as symp-
toms of heart failure and RV arrhythmias.
Characteristic clinical features of an overlap disease of BrS and
ARVC/D remain unclear, and consensus on a better treatment
course for this type of overlap disease remains. After studying the
present case, we recommend EPS evaluation to determine the
phenotype of overlapping disease (e.g., BrS-like or ARVC/D-like)
because clinical features of BrS and those of ARVC/D can coexist in
a single patient. The phenotype observed in this case resembled
BrS rather than ARVC/D. This case had neither late gadolinium
enhancement on CMR nor inducibility of VT/VF during EPS before
pilsicainide infusion. Therefore, the existence of scar areas or
substrates, which are characteristics of ARVC/D, was unlikely. VF
was easily inducible after pilsicainide infusion and was obviously
inhibited after ISP infusion. These ﬁndings exactly match the
characteristics of BrS. Identiﬁcation of the phenotype of over-
lapping disease is important because responses to exercises or
drugs, such as beta stimulants or sodium channel blockers, differ
considerably between BrS and ARVC/D. In addition, upon con-
ﬁrmation of the overlap state, the clinician should recall that the
phenotype may change during the clinical course. Therefore, more
attentive follow-up is required. As more cases are discovered and
reported, this disease state will be expected to be clariﬁed further.Conﬂict of interest
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